Scarica l'app Stockscreener
36.00
2.01%
0.72
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$35.28
Aprire:
$35.66
Volume 24 ore:
1.11M
Relative Volume:
0.28
Capitalizzazione di mercato:
$15.56B
Reddito:
$2.31B
Utile/perdita netta:
$1.66B
Rapporto P/E:
15.65
EPS:
2.3
Flusso di cassa netto:
$827.02M
1 W Prestazione:
+0.61%
1M Prestazione:
+0.02%
6M Prestazione:
+15.46%
1 anno Prestazione:
+26.81%
Intervallo 1D:
$35.53
$36.05
Intervallo di 1 settimana:
$34.63
$36.05
Portata 52W:
$24.05
$38.00
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
35.99 | 15.25B | 2.31B | 1.66B | 827.02M | 2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.89 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.64 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.50 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
775.48 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
345.21 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Goldman | Buy |
| 2025-05-16 | Iniziato | Morgan Stanley | Overweight |
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Royalty Pharma : Q3 2025 Pre-Quarterly Results Communication - MarketScreener
Goldman Sachs Initiates Coverage of Royalty Pharma (RPRX) with Buy Recommendation - Nasdaq
Royalty Pharma plc Stock Analysis and ForecastPrice Action Analysis & High Profit Investment Ideas - earlytimes.in
Goldman Sachs initiates Royalty Pharma stock with Buy rating, $42 target - Investing.com UK
Why Royalty Pharma plc (RPD) stock could rally strongly2025 AllTime Highs & Weekly Top Gainers Trade List - newser.com
Goldman Sachs Starts Royalty Pharma (RPRX) at Buy, PT $42 - StreetInsider
Why Royalty Pharma plc stock is a must watch in 2025Market Growth Review & High Conviction Investment Ideas - newser.com
Is Royalty Pharma plc stock a smart buy before Fed meeting2025 Buyback Activity & Fast Gain Stock Trading Tips - newser.com
Understanding Royalty Pharma plc’s price movement2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
Royalty Pharma : Bernstein Healthcare Forum Transcript - MarketScreener
Royalty Pharma appoints Ted Love as lead independent director - Investing.com
Royalty Pharma names Dr. Ted Love as lead independent director - StreetInsider
Biotech Leader Ted Love Takes Key Board Role at Royalty Pharma, Bringing BIO Leadership Experience - Stock Titan
What candlestick patterns are forming on Royalty Pharma plcEarnings Trend Report & Stepwise Trade Execution Plans - newser.com
Will Royalty Pharma plc stock see PE expansion2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com
Overbrook Management Corp Trims Position in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc RPD a good long term investmentStock Liquidity Analysis & Fast Growing Investment Plans - earlytimes.in
What analysts say about Royalty Pharma plc RPD stockDividend Reinvestment Plans & Free Tools to Monitor Market Corrections - Early Times
Assessing Royalty Pharma (RPRX): Is the Recent Outperformance Reflected in Its Current Valuation? - Yahoo Finance
Bank Pictet & Cie Europe AG Cuts Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - 富途牛牛
Ruffer LLP Makes New $6.41 Million Investment in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth - Insider Monkey
Wedge Capital Management L L P NC Grows Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma at Bernstein Forum: Strategic Insights on Growth - Investing.com South Africa
Royalty Pharma at Bernstein Forum: Strategic Insights on Growth By Investing.com - Investing.com UK
Transcript : Royalty Pharma plc Presents at Bernstein Insights - MarketScreener
Mn Services Vermogensbeheer B.V. Acquires Shares of 67,000 Royalty Pharma PLC $RPRX - MarketBeat
Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood? - MSN
Royalty Pharma PLC $RPRX Shares Sold by Ridgewood Investments LLC - MarketBeat
Strs Ohio Invests $1.89 Million in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum - The Manila Times
Pacific Capital Partners Ltd Sells 77,500 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Sell Signal: Does HAIN align with a passive investing strategyPortfolio Gains Report & Fast Momentum Entry Tips - khodrobank.com
Analyst Downgrade: Why is Royalty Pharma plc stock going downJuly 2025 Trends & AI Enhanced Trading Alerts - khodrobank.com
Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today - Sahm
Leading Biopharma Royalty Investor Royalty Pharma Featured at Bernstein Healthcare Forum 2025 - Stock Titan
Layoff Watch: Will Royalty Pharma plc benefit from rate cutsWeekly Trend Recap & Stock Market Timing Techniques - khodrobank.com
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 226,048 Shares of Royalty Pharma PLC $RPRX - MarketBeat
How to contact the Daily Bulletin - FinancialContent
Market Outlook: Should I buy Royalty Pharma plc stock now2025 Market Overview & Daily Entry Point Alerts - خودرو بانک
Nasdaq Moves: What are the analyst revisions for GCLWWIs Royalty Pharma plc stock a good investment in YEARJuly 2025 Macro Moves & Verified Chart Pattern Trade Signals - خودرو بانک
Royalty Pharma’s $2 Billion Debt Offering Could Be a Game Changer for RPRX - simplywall.st
TD Cowen Maintains a Buy on Royalty Pharma (RPRX) - Insider Monkey
Royalty Pharma Plc Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo
Syndax, Royalty Pharma enter into $350M royalty funding deal - MSN
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):